The page is the record's research on the issuer — no analyst, no rating, no view. # Immuron Ltd (NASDAQ: IMRN) — research page As of 2026-11-08 · us-cm-kg · record version 1 ## Identity and listing The issuer is Immuron Ltd, listed on NASDAQ under ticker IMRN. Its ISIN is US45254U1016 and its LEI is 529900ZIDI5C9C9TTI91. Its security type is recorded as non-operating entity type (other). Its segment is not on the record. Its sector is 2834 Pharmaceutical Preparations and its jurisdiction is Australia. Its status is listed, not halted. ## The disclosure read The record holds 54 filings in the window from 2025-11-08 to 2026-11-08, across 46 filing days. Of these, 45 are results, 8 are directors' dealings and 1 is a prospectus. The median gap between filing days is 5 days. The latest filing is dated 2026-10-28 and is of type results, 11 days before the record date of 2026-11-08, so latency is 11 days. The NASDAQ exchange median is 52 filings, a cadence gap of 6.0 days and a latency of 5.0 days. The sector median for 2834 Pharmaceutical Preparations across 526 issuers is 63.0 filings, a cadence gap of 6.0 days and a latency of 4.0 days. ## Auditor The auditor is not on the record, because the latest annual report cover carries no dei:AuditorName tag. The auditor's location is not on the record. The record holds no auditor changes. ## Events and halts The record holds no listing, delisting or name change lines. The domicile change is not on the record, as EDGAR states no dated change of state of incorporation on a filing line. The segment move is not on the record, as the exchanges' tier transfers are not EDGAR filings. The halt flag is listed, not halted. ## Orderability The outcome is not determinable, because the chapter's orderability section carries no client categories, so the outcome cannot name its client category. The rule version is acm-68000/us/reasonable-basis-suitability-finra-rule-2111/r1, and the chapter is as of 2026-11-04. ## Coverage No research houses were found on the issuer's own investor-relations page, so the count is 0. ## Open research No openly published research notes were found, so the count is 0. ## Licensed Licensed research: none loaded. A licensed row is served only to an agent whose firm holds that licence (licensor, entitlement). No licensed row is loaded. ## As-of depth The issuer's years sealed are 2021, 2022, 2023, 2024, 2025 and 2026. The market's earliest sealed date is 2021-01-04. The live record began on 2026-09-12. ## Sources 8 source pages are named on this page; every value above carries its own source page and read date in the numbers. - https://www.sec.gov/files/company_tickers_exchange.json (identity.exchange) - https://www.sec.gov/data-research/sec-markets-data/fails-deliver-data (identity.isin) - https://data.sec.gov/submissions/CIK0001660046.json (identity.jurisdiction) - https://mapping.gleif.org/api/v2/isin-lei/latest/download (identity.lei) - https://mcp.us-cm-kg.ai/events/NASDAQ/IMRN (the disclosure lines) - https://www.nasdaqtrader.com/rss.aspx?feed=tradehalts (the halt flag) - https://mcp.us-cm-kg.ai/book/aio.json (the orderability chapter) - https://mcp.us-cm-kg.ai/record/NASDAQ/IMRN (the record) --- Allooloo Technologies Corp. · https://getresearch.ai/us/NASDAQ/IMRN · public-record only · the same page signed and receipted: get_research at https://mcp.getresearch.ai/mcp